2024-04-25 20:57:07 ET
Teladoc Health, Inc. (TDOC)
Q1 2024 Earnings Call Transcript
April 25, 2024 05:00 PM ET
Company Participants
Adam Vandervoort - Chief Legal Officer
Mala Murthy - Acting Chief Executive Officer and Chief Financial Officer
Laizer Kornwasser - President of Enterprise Growth and Global Markets.
Conference Call Participants
Stephanie Davis - Barclays
Lisa Gill - JPMorgan
Jailendra Singh - Truist
Jessica Tassan - Piper Sandler
Sean Dodge - RBC Capital
Allen Lutz - Bank of America
Sarah James - Cantor Fitzgerald
George Hill - Deutsche Bank
Elizabeth Anderson - Evercore
Daniel Grosslight - Citi
Presentation
Operator
Good afternoon. Thank you for attending the Teladoc Health Q1 2024 Earnings Call. My name is Matt, and I'll be your moderator for today's call. All lines have be muted during the presentation portion of the call. There'll be some opportunity for questions and answers at the end. [Operator Instructions]
I would like to pass the conference over to our host, Adam Vandervoort, Chief Legal Officer, Teladoc. Adam, please go ahead.
Adam Vandervoort
Thank you and good afternoon. Today, after the market closed, we issued a press release announcing our first quarter 2024 financial results. This press release and the accompanying slide presentation are available in the Investor Relations section of the teladochealth.com website.
On this call to discuss the results are: Mala Murthy, our Acting Chief Executive Officer and Chief Financial Officer; and Laizer Kornwasser, our President of Enterprise Growth and Global Markets.
During this call, we will also discuss our outlook. And our prepared remarks will be followed by a question-and-answer session. Please note that we will be discussing certain non-GAAP financial measures that we believe are important in evaluating Teladoc Health's performance. Details on the relationship between these non-GAAP measures to the most comparable GAAP measures and reconciliations thereof can be found in the press release that is posted on our website.
Also, please note that certain statements made during this call will be forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, uncertainties, and other factors that could cause the actual results for Teladoc Health to differ materially from those expressed or implied on this call. For additional information, please refer to our cautionary statement in our press release and our filings with the SEC, all of which are available on our website....
Read the full article on Seeking Alpha
For further details see:
Teladoc Health, Inc. (TDOC) Q1 2024 Earnings Call Transcript